Faculty

Institution

Unit

Venue

Jaya Kala, MD

Associate Professor Renal Diseases and Hypertension Chief Onco-Nephrology

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Nephrology

Jaya Kala, Md is currently serving as a Nephrology Associate Professor Renal Diseases and Hypertension Chief Onco-Nephrology at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jaya Kala, MD

The University of Texas MD Anderson Cancer Center

Associate Professor Renal Diseases and Hypertension Chief Onco-Nephrology

You can click a keyword to filter the displayed items

nephrology medicine pharmacology urology oncology chronic kidney disease cancer care renal function hematology vascular biology medicinal research immunology cancer research clinical biochemistry cancer treatment kidney research clinical case presentation tumor biology inflammation cancer immunotherapy cancer discovery cellular therapy internal medicine cardiovascular research clinical transplantation pharmacotherapy case studies genitourinary cancers immune checkpoint inhibitors position statement cancer imaging molecular diagnostics liver physiology health systems medical physics jama oncology cancer genomics prognostic biomarkers oncologic imaging cancer disparities reference frame multi-omics studies future scenario feedback loop cancer management patient-reported outcomes radiation effects radiation biology radiation exposure clinical evidence clinical immunology renal care pharmacoeconomics antihypertensive therapy electrode-electrolyte interfaces magnesium-based composite case analysis empirical case studies clinical case report case series immunologic diseases medicare cancer patients retrospective study conventional care radiation-induced kidney injury successful treatment chemotherapeutic agents economic value mtx elimination delayed mtx elimination risk factors severe hypertension overlooked electrolyte unique case diffuse alveolar hemorrhage pembrolizumab-induced acral vasculitis

Notable Scholarly Works

Notable Federal Grants

Collaborators

Developing an Onconephrology Clinic in a Safety Net Hospital. Journal of the American Society of Nephrology (2025)

patient managementmedical systemspatient safetyhospital medicinehealth carenursinghospital environmentonconephrology clinicclinical nursing

High-Dose Methotrexate Nephrotoxicity. American Journal of Nephrology (2025)

medicinepharmacologyhigh-dose methotrexate nephrotoxicityrenal functiondrug metabolismnephrologyclinical biochemistryapplied pharmacologychronic kidney diseaseblood purificationpharmacotherapyacute kidney injurytranslational medicine

Acute Kidney Injury Associated With Anticancer Therapies: Small Molecules and Targeted Therapies. Kidney360 (2024)

kidney researchpharmacologyanticancer therapiessmall moleculesnephrologyurologycancer immunotherapytherapeutic targetsmedicinal researchcancer cellsacute kidney injurytargeted therapies

Assessment of Gfr in Patients With Cancer. Clinical Journal of the American Society of Nephrology (2024)

Abhijat KitchluVerônica T. Costa E. SilvaShuchi AnandJaya KalaAla AbudayyehLesley A. InkerMitchell H. RosnerSabine KaramPrakash GudsoorkarShruti GuptaSheldon ChenNattawat KlomjitNelson LeungTomaz MilanezShveta S. MotwaniSheikh B. KhalidVinay SrinivasanRimda WanchooJan H. BeumerGeoffrey LiuNizar M. TannirAni Orchanian-CheffYimin GengSandra M. Herrmann

medicinecancer caregliomascancer researchepidemiologyvascular biologycancer discoverycancer genomicsgenitourinary cancerscancer imagingbiostatisticsoncologymolecular diagnosticsprognostic biomarkerstumor microenvironmenttumor biologyoncologic imagingcancer disparities

Cover Image. Kidney360 (2024)

Diagnosis and Management of Immune Checkpoint Inhibitor–Associated Nephrotoxicity: A Position Statement From the American Society of Onco-Nephrology. Kidney International (2024)

Sandra M HerrmannAla AbudayyehShruti GuptaPrakash GudsoorkarNattawat KlomjitShveta S MotwaniSabine KaramVerônica T Costa E SilvaSheikh B KhalidShuchi AnandJaya KalaDavid E LeafNaoka MurakamiArash RashidiRimda WanchooAbhijat Kitchlu

metastasissurvival analysisreference framemulti-omics studiesliver physiologyneurologyfuture scenariovascular biologyinflammationdermatologyhospital medicineposition statementcase studiestumor biologypharmacologycardiovascular researchmedicinal researchfeedback loopcellular therapy

Isosorbide Mononitrate (Imn) for Anti-Vascular Endothelial Growth Factor (Vegf)-Induced Kidney Injury. Journal of the American Society of Nephrology (2024)

Jaya KalaKevin W. Finkel

medicinekidney researchkidney injuryvascular biologynephrologyurologychronic kidney diseasewound healingimmunotherapyvascular surgeryrenal functioncardiovascular researchbiomolecular engineeringendothelial dysfunctionrenal pathophysiologymedicinal researchacute kidney injuryisosorbide mononitrateclinical transplantationcardiovascular disease

Recommendations for the Assessment of Glomerular Filtration Rate in Patients With Cancer: A Position Statement and Systematic Review on Behalf of the American Society of Onco-Nephrology (Ason).. Journal of Clinical Oncology (2024)

Abhijat KitchluVeronica Torres Costa E SilvaShuchi AnandJaya KalaAla AbudayyehLesley InkerGeoffrey LiuNelson LeungSandra M Herrmann

neurologycancer caredisease assessmentradiation oncologynephrologyveterinary medicinesystematic reviewposition statementgenitourinary cancersglomerular filtration rateoncologyclinical researchrespiratory medicinehealth sciences

Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer. Kidney International Reports (2024)

pharmacologycancer carerenal functioncancer researchurologycancer discoveryhypertensiononcologyantihypertensive therapyrisk factorscancer treatmentjama oncologysevere hypertension

Glucarpidase for Treating Adults With Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis. ClinicoEconomics and Outcomes Research (2023)

Jaya KalaRebecca NelsonChristopher DrudgeAllen ZhouSuzanne WardMegan Bourque

economic valuemedicineinternal medicinerenal functionmtx eliminationnephrologyurologyclinical biochemistrychronic kidney diseasedelayed mtx eliminationhealth sciencespharmacoeconomics

1
2
3
10 / page

Jaya Kala, MD

Associate Professor Renal Diseases and Hypertension Chief Onco-Nephrology

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Nephrology

Jaya Kala, Md is currently serving as a Nephrology Associate Professor Renal Diseases and Hypertension Chief Onco-Nephrology at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jaya Kala, MD

The University of Texas MD Anderson Cancer Center

Associate Professor Renal Diseases and Hypertension Chief Onco-Nephrology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Developing an Onconephrology Clinic in a Safety Net Hospital. Journal of the American Society of Nephrology (2025)

patient managementmedical systemspatient safetyhospital medicinehealth carenursinghospital environmentonconephrology clinicclinical nursing

High-Dose Methotrexate Nephrotoxicity. American Journal of Nephrology (2025)

Acute Kidney Injury Associated With Anticancer Therapies: Small Molecules and Targeted Therapies. Kidney360 (2024)

kidney researchpharmacologyanticancer therapiessmall moleculesnephrologyurologycancer immunotherapytherapeutic targetsmedicinal researchcancer cellsacute kidney injurytargeted therapies

Assessment of Gfr in Patients With Cancer. Clinical Journal of the American Society of Nephrology (2024)

Cover Image. Kidney360 (2024)

Diagnosis and Management of Immune Checkpoint Inhibitor–Associated Nephrotoxicity: A Position Statement From the American Society of Onco-Nephrology. Kidney International (2024)

Isosorbide Mononitrate (Imn) for Anti-Vascular Endothelial Growth Factor (Vegf)-Induced Kidney Injury. Journal of the American Society of Nephrology (2024)

Jaya KalaKevin W. Finkel

Abhijat KitchluVeronica Torres Costa E SilvaShuchi AnandJaya KalaAla AbudayyehLesley InkerGeoffrey LiuNelson LeungSandra M Herrmann

pharmacologycancer carerenal functioncancer researchurologycancer discoveryhypertensiononcologyantihypertensive therapyrisk factorscancer treatmentjama oncologysevere hypertension

Glucarpidase for Treating Adults With Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis. ClinicoEconomics and Outcomes Research (2023)

Jaya KalaRebecca NelsonChristopher DrudgeAllen ZhouSuzanne WardMegan Bourque

economic valuemedicineinternal medicinerenal functionmtx eliminationnephrologyurologyclinical biochemistrychronic kidney diseasedelayed mtx eliminationhealth sciencespharmacoeconomics

1
2
3
10 / page